CYP4F2 polymorphism as a genetic risk factor for major hemorrhagic complications in Chinese patients on warfarin therapy
J Geriatr Cardiol
.
2012 Jun;9(2):209-10.
doi: 10.3724/SP.J.1263.2012.04162.
Authors
Hong-Juan Wang
1
,
Cong Ma
,
Jie Yang
,
Qiang Xu
,
Yan Zhang
,
Lei Gao
,
Bin Xu
,
Yu-Xiao Zhang
,
Yang Li
,
Tong Yin
Affiliation
1
Institute of Geriatric Cardiology, General Hospital of Chinese People's Liberation Army, Beijing 100853, China.
PMID:
23097648
PMCID:
PMC3418912
DOI:
10.3724/SP.J.1263.2012.04162
No abstract available
Keywords:
CYP4F2; Complications; Genetic risk factor; Warfarin.